5 recent pharmaceutical lawsuits, settlements

Below are five legal actions involving members of the drug supply chain, including pharmaceutical manufacturers and distributors, reported by Becker’s Hospital Review in the last week:

Advertisement
  1. Oklahoma sues McKesson, Cardinal, AmerisourceBergen over the opioid crisis
    Oklahoma Attorney General Mike Hunter filed a lawsuit against Cardinal Health, McKesson and AmerisourceBergen, three of the country’s largest drug distributors, alleging they helped fuel the opioid crisis by funnelling “unreasonable” amounts of opioids into the state.
  2. Roche pulled a $1.5B fast one on US, whistleblower physician alleges
    Roche allegedly misled the U.S. government about the effectiveness of its drug, Tamiflu, at combating a flu pandemic, causing the government to unnecessarily spend $1.5 billion to stockpile the drug.
  3. Endo settles Oklahoma opioid case for $8.8M
    Endo Pharmaceuticals agreed to pay $8.8 million to Oklahoma to settle claims its marketing played a role in fueling the opioid crisis.
  4. J&J agrees to $6.3M settlement linked to marketing of Infants’ Tylenol
    Johnson & Johnson has agreed to pay up to $6.3 million to customers who bought Infants’ Tylenol since 2014 to settle a lawsuit claiming deceptive marketing practices.
  5. Bristol-Myers, Sanofi sue Hawaii, accused of violating their free speech
    Bristol-Myers Squibb and Sanofi, two of the world’s largest drugmakers, filed a lawsuit against Hawaii Attorney General Clare Connors, claiming she violated their First Amendment rights.

More articles on pharmacy:
CVS to add 600 HealthHUBs, link them to lower Aetna copays
Civica Rx calls on generic drugmakers to donate to its cause
Pfizer, GlaxoSmithKline give timeline for IPO of joint venture

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.